Aavas Financiers Ltd – Stock Analysis (Weekly Chart & Fundamentals)

Date:

Share post:

A strong bullish candle has formed on Aavas Finance’s weekly chart, accompanied by high volume—the highest volume seen in the past year.

Technical Analysis:

1.The stock had been trading sideways for a long time but is now showing momentum with volume.
2.If this breakout is confirmed, a good upside move could be expected.

Fundamental Analysis:

Market Cap: ₹15,046 crore
EPS (Earnings Per Share): ₹71.1
P/E Ratio: 26.7 (Moderate valuation, but growth potential may justify it.)

Revenue Growth:

March 2013: ₹18 crore
March 2024: ₹2,018 crore 🚀 (Impressive 10-year growth!)
Financing Margin: Continually improving, which is a positive signal for profitability.
Reserves: Increasing steadily, indicating financial strength and stability.

 

Stock Price Vs. Fundamentals:

The company’s sales and profit are growing, but the stock price has not moved aggressively.
This could mean the market is still digesting valuation or liquidity factors.

Institutional Holding (Smart Money Presence):

FII Holding (Dec 2024): 33.97% (Strong confidence from foreign investors)
DII Holding (Dec 2024): 25.69% (Domestic institutions also hold a good stake)

Final Thoughts:
✅ Technical breakout + high volume could be a bullish signal.
✅ Strong fundamentals – revenue, profit, and reserves are growing consistently.
✅ Strong institutional holding by FIIs and DIIs, indicating stability.

⚠️ Breakout confirmation is crucial – if it sustains, a strong upside rally could follow!

Related articles

KEC International: A Global EPC Powerhouse Driving Infrastructure Growth Across Sectors

KEC International is a global infrastructure EPC (Engineering, Procurement & Construction) major. The company operates across multiple sectors, such...

ITD Cementation Set for Strong FY26 on Robust Order Pipeline and Adani Synergy

ITD Cementation delivered solid growth in FY25, and with a strong order pipeline and synergy with Adani in...

Piramal Pharma: A Re-Emerging Pharma Player with Strong Growth Ambitions

Piramal Pharma Limited (PPL), a part of the Piramal Group, operates across three key segments: Contract Development and Manufacturing...

Cement Sector Consolidation: Ambuja Acquires Majority Stake in Orient Cement

Ambuja Cements has acquired a 37.8% stake in Orient Cement, marking a significant consolidation move in the Indian...
WhatsApp chat